Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ.

Ann Rheum Dis. 2011 Sep;70(9):1550-5. doi: 10.1136/ard.2010.148031. Epub 2011 Jul 4.

2.

Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.

Foster W, Carruthers D, Lip GY, Blann AD.

J Rheumatol. 2010 Apr;37(4):711-6. doi: 10.3899/jrheum.090699. Epub 2010 Feb 15.

PMID:
20156948
3.

The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.

Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ.

J Am Heart Assoc. 2013 Nov 19;2(6):e000441. doi: 10.1161/JAHA.113.000441.

4.

Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.

Syngle A, Vohra K, Kaur L, Sharma S.

Scand J Rheumatol. 2009 Jan-Feb;38(1):15-22. doi: 10.1080/03009740802279709.

PMID:
18766955
5.

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2011 Mar;13(3):147-52.

6.

Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.

Guin A, Chatterjee Adhikari M, Chakraborty S, Sinhamahapatra P, Ghosh A.

Semin Arthritis Rheum. 2013 Aug;43(1):48-54. doi: 10.1016/j.semarthrit.2012.12.027. Epub 2013 Feb 12.

PMID:
23415602
7.

Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.

Hjeltnes G, Hollan I, Førre Ø, Wiik A, Mikkelsen K, Agewall S.

Scand J Rheumatol. 2011 Nov;40(6):422-7. doi: 10.3109/03009742.2011.585350.

PMID:
22150462
8.

Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.

Syngle A, Vohra K, Garg N, Kaur L, Chand P.

Int J Rheum Dis. 2012 Feb;15(1):45-55. doi: 10.1111/j.1756-185X.2011.01679.x. Epub 2011 Oct 10.

PMID:
22324946
9.

Arterial stiffness in a muscular artery in women with longstanding rheumatoid arthritis compared with healthy controls and patients with traditional cardiovascular risk factors.

Pieringer H, Stuby U, Pohanka E, Biesenbach G.

Rheumatol Int. 2010 Aug;30(10):1335-9. doi: 10.1007/s00296-009-1155-5. Epub 2009 Oct 13.

PMID:
19823841
10.

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.

11.

Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Béchir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F.

Circulation. 2002 Oct 22;106(17):2184-7.

12.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
13.

Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.

Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.

Circulation. 2006 Sep 12;114(11):1185-92. Epub 2006 Sep 4.

14.

Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.

Dessein PH, Joffe BI, Singh S.

Arthritis Res Ther. 2005;7(3):R634-43. Epub 2005 Mar 24.

15.

Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.

Galarraga B, Belch JJ, Pullar T, Ogston S, Khan F.

J Rheumatol. 2010 Mar;37(3):521-8. doi: 10.3899/jrheum.090417. Epub 2010 Jan 15.

PMID:
20080919
16.

Vitamin D deficiency, interleukin 17, and vascular function in rheumatoid arthritis.

Ranganathan P, Khalatbari S, Yalavarthi S, Marder W, Brook R, Kaplan MJ.

J Rheumatol. 2013 Sep;40(9):1529-34. doi: 10.3899/jrheum.130012. Epub 2013 Jul 1.

17.

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

Quartuccio L, Fabris M, Salvin S, Atzeni F, Saracco M, Benucci M, Cimmino M, Morassi P, Masolini P, Pellerito R, Cutolo M, Puttini PS, De Vita S.

Rheumatology (Oxford). 2009 Dec;48(12):1557-9. doi: 10.1093/rheumatology/kep314. Epub 2009 Sep 29.

PMID:
19789202
18.

Predictors of endothelial dysfunction in patients with rheumatoid arthritis.

Sarli B, Baktir AO, Cebicci M, Dogan Y, Demirbas M, Kurtul S, Saglam H, Akpek M, Sahin O, Arinc H.

Angiology. 2014 Oct;65(9):778-82. doi: 10.1177/0003319713504485. Epub 2013 Sep 26.

PMID:
24078515
19.

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E.

Ann Rheum Dis. 2004 Jan;63(1):31-5.

20.

A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.

Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP.

Atherosclerosis. 2011 Dec;219(2):734-6. doi: 10.1016/j.atherosclerosis.2011.09.015. Epub 2011 Sep 16.

PMID:
21968316

Supplemental Content

Support Center